Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells

Blood

Volumn 97, Issue 12, 2001, Pages 3976-3983

  Joiner, Clinton H ^a,b   Jiang, Maorong ^a   Claussen, William J ^a   Roszell, Nancy J ^a   Yasin, Zahida ^a   Franco, Robert S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DIPYRIDAMOLE; POTASSIUM; POTASSIUM CHANNEL; SODIUM;

ARTICLE; CALCIUM TRANSPORT; CATION TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE MEMBRANE; FLUOROMETRY; HEMATOCRIT; HUMAN; HUMAN CELL; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SICKLE CELL; SODIUM TRANSPORT;

EID: 0035877974     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3976     Document Type: Article

References (39)

1. Horiuchi K, Onyike AE, Osterhout ML. Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension. Exp Hematol. 1998;24:68-76.
2. Joiner CH, Morris CL, Cooper ES. Deoxygenation-induced cation fluxes in sickle cells, III: cation selectivity and response to pH and membrane potential. Am J Physiol. 1993;264:C734-C744.
3. Joiner CH, Jiang M, Franco RS. Deoxygenation-induced cation fluxes in sickle cells, IV: modulation by external calcium. Am J Physiol. 1995;269:C403-C409.
4. Bookchin RM, Ortiz OE, Lew VL. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest. 1991;87:113-124.
5. Ortiz OE, Lew VL, Bookchin RM. Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells. J Physiol. 1990;427:211-226.
6. ++ permeability in deoxygenated sickle cells. Blood. 1990;75:2453-2458.
7. 2+ levels of sickle cell anemia red cells. J Clin Invest. 1993;2:2489-2498.
8. 2+ permeability. J Clin Invest. 1997;99:2727-2735.
9. Joiner CH, Platt OS, Lux SE. Cation depletion by the sodium pump in red cells with pathological cation leaks: sickle cells and xerocytes. J Clin Invest. 1986;78:1487-1496.
10. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest. 1993;92:520-526.
11. Franco RS, Palascak M, Thompson H, Rucknagel DL, Joiner CH. Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: role of KCl cotransport and extracellular calcium. Blood. 1996;88:4359-4365.
12. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990;40:63-279.
13. Joiner CH, Gunn RB, Fröhlich O. Anion transport in sickle red blood cells. Pediatr Res. 1990;28:587-590.
14. Joiner CH. Deoxygenation-induced fluxes in sickle cells, II: inhibition by stilbene disulfonates. Blood. 1990;76:212-220.
15. Ohnishi S, Horiuchi KY, Horiuchi K, Jurman ME, Sadanaga KK. Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells. Pharmacology. 1986;32:248-256.
16. Joiner CH, Jiang M. Inhibition of deoxygenation-induced calcium influx in sickle red blood cells by dipyridamole and other transport inhibitors [abstract]. Blood. 1995;86:299a.
17. Joiner CH, Jiang M. Dipyridamole inhibits deoxygenation-induced cation fluxes in sickle cells. In: Rosa J, Beuzard Y, Lubin B, eds, New Trends in Therapies for Hemoglobinopathies and Thalassemias. Paris, France: INSERM/John Libbey; 1995:525-542.
18. Legrum B, Passow H. Inhibition of inorganic anion transport across the human red blood cell membrane by choloride-dependent association of dipyridamole with a stilbene disulfonate binding site on the band 3 protein. Biochim Biophys Acta. 1989;979:193-207.
19. Kalsi KK, Smolenski RT, Yacoub MH. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. Mol Cell Biochem. 1998;180:193-199.
20. Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem. 1998;273:15559-15564.
21. Szasz I, Sarkadi B, Gardos G. Effect of drugs on the calcium-dependent rapid potassium transport in calcium-loaded intact red cells. Acta Biochim Biophys Acad Sci Hung. 1978;13:133-141.
22. i level and pump-leak turnover in intact red cells measured using an incorporated Ca chelator. Nature. 1982;298:478-481.
23. Lowry OH, Rosebrought NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
24. Eaton JW, Branda RF, Hoadland C, Dreher K. Anion channel blockade: effects on erythrocyte membrane calcium response. Am J Hematol. 1980;9:391-399.
25. Bennekou P, Pedersen O, Moller A, Christophersen P. Volume control in sickle cells is facilitated by the novel anion conductance inhibitor NS1652. Blood. 2000;95:1842-1848.
26. Knauf PA, Law FY, Marchant PJ. Relationship between net chloride flow across the human erythrocyte membrane to the anion exchange mechanism. J Gen Physiol 1984;81:95-104.
27. Joiner CH, Jiang M, Fathallah H, Giraud F, Franco RS. Deoxygenation of sickle red blood cells stimulates KCl cotransport without affecting Na/H exchange. Am J Physiol. 1998;274:C1466-C1475.
28. Iuliano L, Colavita AR, Camastra C, et al. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br J Pharmacol. 1996;119:1438-1446.
29. Johnson RM, Tang K. DIDS inhibition of deformation-induced cation flux in human erythrocytes. Biochim Biophys Acta. 1993;1148:7-14.
30. Sugihara T, Yawata Y, Hebbel RP. Deformation of swollen erythrocytes provides a model of sickling-induced leak pathways, including a novel bromide-sensitive component. Blood. 1994;83:2684-2691.
31. Jiang M, Joiner CH. Non-selective cation channels in sickle membranes spicules are inhibited by DIDS, a stilbene disultonate drug which blocks sickling-induced cation fluxes in intact cells [abstract]. Blood. 1999;94:198a.
32. Bennekou P. The feasibility of pharmacological volume control of sickle cells is dependent on the quantization of the transport pathways: a model study. J Theor Biol. 1999;196:129-137.
33. Chaplin H, Alkjaersig N, Fletcher AP, Michael JM, Joinst JH. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises. Thromb Haemost. 1980;43:218-221.
34. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New Engl J Med. 1995;332:1317-1322.
35. Brugnara C, Gee B, Armsby CC, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 1996;97:1227-1234.
36. + transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. J Clin Invest. 1994;93:1670-1676.
37. Bookchin RM, Tieffert JT, Davies SC, Vichinsky E, Lew VL. Magnesium therapy for sickle cell anemia: a new rationale. In: Rosa J, Beuzard Y, Lubin B, eds. New Trends in Therapies for Hemoglobinopathies and Thalassemias. Paris, France: INSERM/John Libbey; 1995:555-546.
38. De Franceschi L, Beuzard Y, Jouault H, Brugnara C. Modulation of erythrocyte potassium chloride cotransport, potassium, and density by dietary magnesium intake in transgenic SAD mouse. Blood. 1996;88:2738-2744.
39. De Franceschi L, Bachir D, Galacteros F, et al. Oral magniesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 1997;100:1847-1852.